UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000038150
Receipt number R000043487
Scientific Title Prospective study of diverting loop ileostomy in rectal cancer surgery
Date of disclosure of the study information 2019/09/30
Last modified on 2026/04/04 10:38:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective study of diverting loop ileostomy in rectal cancer surgery

Acronym

Prospective study of diverting loop ileostomy in rectal cancer surgery

Scientific Title

Prospective study of diverting loop ileostomy in rectal cancer surgery

Scientific Title:Acronym

Prospective study of diverting loop ileostomy in rectal cancer surgery

Region

Japan


Condition

Condition

rectal cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to investigate the relationship between diverting loop ileostomy orientation and complication rate in the creation of diverting loop ileostomy for rectal cancer surgery.

Basic objectives2

Others

Basic objectives -Others

To assess complications after closure of diverting loop ileostomy.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

To evaluate the rate of intestinal obstruction.

Key secondary outcomes

To evaluate fasting period, period until start of oral ingestion after surgery, nasal tube insertion period, period of tube insertion via ileostomy, necessity of operation for intestinal obstruction, the incidence of SSI, the rate of stoma-related morbidity, other postoperative complications, operation time, and bleeding volume.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Patients with rectal cancer who will have diverting loop ileostomy.
2) Surgery is AR / LAR / ISR.
3) No history of surgery with intestinal resection (except for appendectomy).
4) No history of intestinal obstruction.
5) Age at the time of registration is 20 years or older.
6) Operable general condition, organ function.
7) Performance Status (ECOG) is either 0 or 1.
8) A written consent has been obtained from the patient for participation in the study.

Key exclusion criteria

1) Cases with the following serious complications
1: Poorly controlled diabetes
2: Uncontrolled heart failure, angina, hypertension, and arrhythmia
3: Interstitial pneumonia, pulmonary fibrosis, advanced emphysema
4: Continuous systemic administration of steroids.
2) Patients with psychosis are considered inappropriate to participate in this study.
3) Cases without a written consent.
4) Cases judged as inappropriate by doctors.

Target sample size

350


Research contact person

Name of lead principal investigator

1st name Mizushima
Middle name
Last name Tsunekazu

Organization

Osaka University Graduate School of Medicine

Division name

Department of Gastroenterological Surgery

Zip code

565-0871

Address

2-2, E-2, Yamadaoka, Suita, Osaka, Japan

TEL

06-6879-3251

Email

tmizushima@gesurg.med.osaka-u.ac.jp


Public contact

Name of contact person

1st name Matsuda
Middle name
Last name Chu

Organization

Osaka University Graduate School of Medicine

Division name

Department of Gastroenterological Surgery

Zip code

565-0871

Address

2-2, E-2, Yamadaoka, Suita, Osaka, Japan

TEL

06-6879-3251

Homepage URL


Email

cmatsuda@gesurg.med.osaka-u.ac.jp


Sponsor or person

Institute

Osaka University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

SCCRE

Address

2-2, E21-25C, Yamadaoka, Suita, Osaka, Japan

Tel

06-6879-3257

Email

miomikamori@gesurg.med.osaka-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大阪大学(大阪府)


Other administrative information

Date of disclosure of the study information

2019 Year 09 Month 30 Day


Related information

URL releasing protocol

none

Publication of results

Published


Result

URL related to results and publications

https://pubmed.ncbi.nlm.nih.gov/39516112/

Number of participants that the trial has enrolled

451

Results

Results: Small-bowel obstruction was observed in 10.8% in the nonrotated group and 12.3% in the rotated group, with no significant difference (P > .99). The only risk factor identified for small-bowel obstructionwas distance from the ileocecal valve, with a significant difference in 16 patients (7.3%) with a distance of <30 cm and 16 patients (15.4%) in a distance of >30 cm (P = .028).
Conclusion: Rotation of the diverting loop ileostomy had no significant effect on the incidence of smallbowel obstruction.

Results date posted

2026 Year 04 Month 04 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

This multicenter prospective study was conducted by the Clinical Study Group of Osaka University, which comprises 24 major institutions. Patients with rectal adenocarcinoma scheduled for laparoscopic/robotic low anterior resection or intersphincteric resection with a diverting loop ileostomy were included. A total of 451 patients were prospectively enrolled between July 2015 and April 2021.

Participant flow

Between July 30, 2015, and April 21, 2021, a total of 451 patients were prospectively enrolled in this study (Figure). Among these, 127 were excluded from the analysis (90 did not undergo diverting loop ileostomy, 18 had missing data, 11 underwent open surgery, 6 had a history of intestinal resection or small-bowel obstruction, 1 underwent proctocolectomy with ileal pouch-anal anastomosis, and 1 withdrew consent). Hence, only 324 patients were included in this analysis.

Adverse events

A small-bowel obstruction of grade III or higher according to the Clavien-Dindo classification occurred in 32 patients (9.9%). No recurrence was observed in these 32 patients. In 22 patients (68.8%), the obstruction possibly originated in the ileostomy site. Among the 32 patients, 6 underwent surgical treatment, which involved early closure of the ileostomy, whereas the remaining 26 showed improvement with conservative treatment with nasoenteric tubes, which was combined with tube insertion through the ileostomy in 17 patients. Small-bowel obstruction was observed in 23 patients (9.2%) in the nonrotated group and 9 patients (12.0%) in the rotated group, with no significant difference (P = .509) (Table IV). The difference was also not significant respect to the rates of small-bowel obstruction requiring revisional surgery, early small-bowel obstruction,21 and length of hospital stay between the nonrotated and rotated groups (2.0% vs 1.3%, P > .99, 7.6% vs 12.0%, P =.245, and 19.6 days vs 22.5 days, P = .935). The only risk factor identified for small-bowel obstructionwas distance from the ileocecal valve, with a significant difference in 16 patients (7.3%) at a distance of >30 cm and in another 16 patients (15.4%) at a distance of>30 cm.

Outcome measures

The primary endpoint was the relevance of loop ileostomy rotation to the incidence of small-bowel obstruction as determined by CT criteria, which include small bowel dilatation >3 cm in diameter without significant colonic dilatation and a transition point from dilated to collapsed small bowel. Contrast agents were also used when necessary for diagnosis. Small-bowel obstruction was defined as obstruction occurring prior to stoma closure or if stoma closure was not performed within 1 year after its creation, and classified as grade III or higher based on the Clavien-Dindo classification system. In this classification system, grade III requiring surgical, endoscopic, or radiologic intervention is further divided into grade IIIa, which requires intervention not under general anesthesia including a nasoenteric tube, and grade IIIb, which requires intervention under general anesthesia. The secondary endpoints included the origin of the small-bowel obstruction, revisional surgery of diverting ileostomy due to small-bowel obstruction, and length of hospital stay.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 05 Month 27 Day

Date of IRB

2015 Year 07 Month 30 Day

Anticipated trial start date

2015 Year 07 Month 30 Day

Last follow-up date

2022 Year 09 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

No longer recruiting


Management information

Registered date

2019 Year 09 Month 29 Day

Last modified on

2026 Year 04 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043487